TECH OUTLOOK 6OCTOBER - 2021EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comPharma is undoubtedly among the fast-developing industries in the world, and its role in the pandemic era is undeniably paramount. With the rapidly changing trends in the landscape, pharmaceutical organisations will further enhance their drug development and manufacturing capabilities. Especially, they will need to revamp their clinical trial management approaches with emerging technology to keep up with the evolving demands of the market. Take AI for instance, which holds tremendous potential for streamlining the development process. AI-based systems will enable biotech and pharma organisations to automate many of the repetitive tasks while also assisting in the planning and reporting functions involved in the clinical trials. The utilisation of AI will also help in organising and prioritising participant information and tracking specific milestones along the clinical trial journey.With all things are considered, there is no doubt that the pharma sector is on the fast track of evolution. Standing at the cusp of clinical trial management technology, there are a wide range of solution providers which offer the latest technologies best suited for the next generation of pharma needs. To help clients steer through the best-of-breed companies, Pharma Tech Outlook has compiled a list of top clinical trial companies. These organisations are transforming the pharmaceutical landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject matter experts, CIOs, and CXOs in the pharma space on the latest industry trends, best practices, recent innovations, and highlights their expertise. Let us know your thoughts!AI Will Revolutionise Clinical Trial ManagementTECH OUTLOOKTECH OUTLOOKCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.OCTOBER - 01 - 2021, Vol 07 - Issue 10 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David Parker
< Page 5 | Page 7 >